Killam Pptys Inc (KMPPF) 8.1834 $KMPPF Killam Apartment

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Killam Pptys Inc (KMPPF) 8.1834 $KMPPF

Killam Apartment REIT Announces Timing of Fourth Quarter and 2015 Results and Conference Call for Killam Properties Inc.
Marketwired - Thu Jan 07, 2:27PM CST
Killam Apartment REIT (TSX: KMP.UN) will be releasing the financial results of Killam Properties Inc. for the year ended December 31, 2015, on Tuesday, February 16, 2016, after the market closes. Killam Properties Inc. was converted to Killam Apartment REIT effective January 1, 2016. A conference call and live audio webcast to discuss the results will be held on Wednesday, February 17, 2016, at 12:00 PM Eastern Time.
KMP-UN.TO: 13.11 (+0.05)

Killam Properties Inc. Finalizes Conversion to a Real Estate Investment Trust
Marketwired - Mon Jan 04, 8:02AM CST
Killam Apartment REIT is pleased to announce that the plan of arrangement (the "Arrangement" to convert Killam Properties Inc. (TSX: KMP) from a corporation to a real estate investment trust ("REIT" was completed effective January 1, 2016. The units of the REIT will begin trading on the Toronto Stock Exchange on Thursday, January 7, 2016, under the symbol KMP.UN. Under the terms of the Arrangement each outstanding common share of Killam Properties Inc. was exchanged for one unit of the REIT, unless a qualifying shareholder elected to receive exchangeable Class B limited partnership units ("Exchangeable Units" in a partnership controlled by the REIT in exchange for their common shares.
KMP.TO: 10.19 (-0.18)

Killam Properties Inc. Announces December 2015 Dividend
Marketwired - Wed Dec 16, 1:01PM CST
Killam Properties Inc. (TSX: KMP) is pleased to announce that its board of directors has declared a dividend pursuant to Killam's monthly dividend policy. The dividend of $0.05 per common share will be paid on January 15, 2016, to shareholders of record on December 31, 2015.
KMP.TO: 10.19 (-0.18)

Killam Properties Inc. Receives Shareholder Approval to Convert to Killam Apartment REIT
Marketwired - Tue Dec 08, 10:32AM CST
Killam Properties Inc. (TSX: KMP) ("Killam" is pleased to announce that is has received shareholder approval of its plan of arrangement (the "Arrangement" to convert Killam from a corporation to a real estate investment trust ("REIT" to be named Killam Apartment REIT. Approval was received at a special meeting of shareholders held today in Halifax, Nova Scotia. Approximately 99.5% of the votes cast were voted in favour of the Arrangement.
KMP.TO: 10.19 (-0.18)

Killam Properties Inc. Reminds Shareholders to Vote In Favour of the Proposed REIT Conversion and Enhances Governance Policies
Marketwire Canada - Mon Nov 30, 8:57AM CST
Killam Properties Inc. (TSX:KMP) ("Killam" reminds shareholders to vote for the proposed plan of arrangement (the "Arrangement" to convert Killam from a corporation to a real estate investment trust ("REIT". Killam's board of directors has unanimously voted in favour of the Arrangement and encourages its shareholders to vote in favour as well. The voting deadline for shareholders is December 3, 2015. The special meeting of shareholders will be held at 11:00 a.m. (Halifax time) on December 8, 2015, at the Courtyard by Marriott, 5120 Salter Street, Halifax, Nova Scotia. If approved by Killam shareholders, the Arrangement is expected to become effective on or about January 1, 2016.
KMP.TO: 10.19 (-0.18)

Killam Properties Inc. Announces November 2015 Dividend
Marketwired - Wed Nov 18, 8:26AM CST
Killam Properties Inc. (TSX: KMP) is pleased to announce that its board of directors has declared a dividend pursuant to Killam's monthly dividend policy. The dividend of $0.05 per common share will be paid on December 15, 2015 to shareholders of record on November 30, 2015.
KMP.TO: 10.19 (-0.18)

Killam Properties Inc. Provides Information on Proposed REIT Conversion
Marketwired - Thu Nov 12, 11:01AM CST
Killam Properties Inc. (TSX: KMP) ("Killam" is pleased to announce that on November 3, 2015, it received an interim order from the Ontario Superior Court of Justice (Commercial List) approving the special meeting of Killam shareholders to consider and approve the proposed plan of arrangement (the "Arrangement" to convert Killam from a corporation to a real estate investment trust ("REIT".
KMP.TO: 10.19 (-0.18)

Killam Properties Inc. Announces Highest Quarterly Earnings in Its History: Third Quarter 2015 Results Highlight $0.24 Per Share in Funds From Operations
Marketwired - Tue Nov 03, 4:02PM CST
Killam Properties Inc. (TSX: KMP) ("Killam" today reported funds from operations ("FFO" per share of $0.24, up from $0.23 in Q3-2014. For the nine months ended September 30, 2015, Killam earned $0.59 in FFO per share, up 9.3% from $0.54 in the same period in 2014.
KMP.TO: 10.19 (-0.18)

Killam Properties Inc. Announces October 2015 Dividend
Marketwired - Mon Oct 19, 2:30PM CDT
Killam Properties Inc. (TSX: KMP) is pleased to announce that its board of directors has declared a dividend pursuant to Killam's monthly dividend policy. The dividend of $0.05 per common share will be paid on November 16, 2015 to shareholders of record on October 30, 2015.
KMP.TO: 10.19 (-0.18)

Killam Properties Inc. Announces Timing of Third Quarter 2015 Results and Conference Call
Marketwired - Fri Oct 09, 9:39AM CDT
Killam Properties Inc. (TSX: KMP) will be releasing its financial results for the third quarter ended September 30, 2015, on Tuesday, November 3, 2015, after the market closes. A conference call to discuss these results will be held on Wednesday, November 4, 2015, at 11:00 AM Eastern Time.
KMP.TO: 10.19 (-0.18)

Killam Properties Inc. Announces September 2015 Dividend
Marketwired - Thu Sep 17, 2:01PM CDT
Killam Properties Inc. (TSX: KMP) is pleased to announce that its board of directors has declared a dividend pursuant to Killam's monthly dividend policy. The dividend of $0.05 per common share will be paid on October 15, 2015 to shareholders of record on September 30, 2015.
KMP.TO: 10.19 (-0.18)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 213

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 25

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 106

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 208

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 166

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 231

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 266

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 270

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 48

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading

Top 5 Most Recently Viewed Articles

Discover How Indovinya's Innovations Boost Sustainable Agriculture

Updated Category News Views 93

Unlocking the Potential of Biopesticides in Agriculture Indovinya introduces innovative solutions to enhance the use of biologically based products amidst a growing drive for sustainable crop protection. Advancements in Biopesticide Utilization The adoption of biopesticides as an alternative to traditional agrochemicals is gaining traction. However, the integration of...

Continue Reading
SCHMID Group Expands Influence with New Equipment Orders

Updated Category News Views 155

SCHMID Group Strengthens Market Position with New Orders In an exciting development from the SCHMID Group, a key player in the equipment manufacturing sector, the company has recently secured significant orders for Panel Level Packaging (PLP) and modified Semi-Additive (mSAP) production equipment. The orders mark a noteworthy advance as SCHMID continues to bolster its...

Continue Reading
X4 Pharmaceuticals Completes Major Equity Financing and Leadership Shift

Updated Category News Views 178

Major Equity Financing by X4 Pharmaceuticals X4 Pharmaceuticals has made headlines recently with its announcement of a significant private equity financing round totaling $60 million. This funding is primarily geared towards advancing the company’s promising treatment for rare immune system diseases, demonstrating their commitment to improving patient outcomes. Leading...

Continue Reading
IGI Secures Fast Track from FDA for Promising Cancer Treatment

Updated Category News Views 124

IGI Receives Fast Track Designation for ISB 2001 Results from the dose-escalation portion of the Phase 1 clinical study of ISB 2001, an innovative treatment for heavily pretreated multiple myeloma patients, will be showcased at an upcoming major oncology conference. This exciting news highlights IGI's continued progress in developing groundbreaking therapies. About ISB...

Continue Reading
Prospera Energy Reports Strong Financial Performance for 2024

Updated Category News Views 163

Prospera Energy's Transformative Year: A Deep Dive into 2024 Financial Results In the recent strategic realignment, Prospera Energy Inc. (TSX.V: PEI, OTC: GXRFF) has successfully pivoted under new leadership, making significant strides in enhancing its production capabilities and financial outlook. This transformation was marked by key appointments, including Shubham Garg...

Continue Reading